Vaginal Dinoprostone Versus Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy
Status:
Recruiting
Trial end date:
2022-01-30
Target enrollment:
Participant gender:
Summary
To compare the effectiveness of vaginal dinoprostone and vaginal Isonicotinic acid hydrazide
in minimizing the pain experienced by postmenopausal patients during diagnostic office
hysteroscopy and to assess the ease of insertion of hysteroscope as reported by the
hysteroscopist.